Proteomics

Dataset Information

0

NEDD8 loss causes cancer vulnerability to immune checkpoint blockade in triple-negative breast cancer


ABSTRACT: We have blocked the expression of some genes in triple-negative breast cancer cell line, MDA-MB-231, and we want to analyse the global protein changes in knockout (KO) versus control cells.

INSTRUMENT(S): LTQ

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Epithelial Cell, Cell Culture

DISEASE(S): Breast Cancer

SUBMITTER: Irineos Papakyriacou  

LAB HEAD: Yumeng Mao

PROVIDER: PXD051061 | Pride | 2024-06-23

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
Ctrl1.raw Raw
Ctrl2.raw Raw
Ctrl3.raw Raw
Ctrl4.raw Raw
KO1.raw Raw
Items per page:
1 - 5 of 8
altmetric image

Publications

Loss of NEDD8 in cancer cells causes vulnerability to immune checkpoint blockade in triple-negative breast cancer.

Papakyriacou Irineos I   Kutkaite Ginte G   Rúbies Bedós Marta M   Nagarajan Divya D   Alford Liam P LP   Menden Michael P MP   Mao Yumeng Y  

Nature communications 20240427 1


Immune checkpoint blockade therapy aims to activate the immune system to eliminate cancer cells. However, clinical benefits are only recorded in a subset of patients. Here, we leverage genome-wide CRISPR/Cas9 screens in a Tumor-Immune co-Culture System focusing on triple-negative breast cancer (TNBC). We reveal that NEDD8 loss in cancer cells causes a vulnerability to nivolumab (anti-PD-1). Genetic deletion of NEDD8 only delays cell division initially but cell proliferation is unaffected after r  ...[more]

Similar Datasets

2024-06-22 | PXD048228 | Pride
2019-11-13 | PXD012762 | Pride
2024-01-08 | PXD046508 | Pride
2023-01-18 | PXD038525 | Pride
2023-09-26 | PXD045562 | Pride
2017-01-27 | E-PROT-2 | biostudies-arrayexpress
2018-10-26 | PXD005928 | Pride
2024-12-18 | PXD051824 | Pride
2018-08-07 | E-MTAB-5447 | biostudies-arrayexpress
2018-12-29 | E-MTAB-7535 | biostudies-arrayexpress